| Revenue growth | 8% YoY for FY26. |
|---|---|
| Margins | FY26 EBITDA margin improved 69 bps to 28%. |
| Order book | Targeting 200+ CT/MRI centres upon completion of current book. |
| Demand visibility | Expanding network to 7-8 states and newer geographies. |
| Management confidence | Strong focus on 'Everyone Can Afford' pricing strategy. |
Growth
FY26 Revenue grew 8% to ₹7.7bn; EBITDA up 10% to ₹2.1bn. PAT surged 31% including a ₹221.75mn valuation gain.
Outlook
Targeting 200+ CT/MRI centers and 5,000+ collection centers. Rajasthan project to significantly scale pathology network.
Risks
Business cyclicity impacting quarterly performance and competitive pricing pressures in the diagnostic industry.
Earnings Call filed with BSE, NSE: KRSNAA. Summary written with AI assistance from the document.
Krsnaa Diagnostics Ltd: key numbers
- Share price
- ₹548.45
- Market cap
- ₹1,779 Cr
- Revenue (annual)
- ₹772.8 Cr
- Net profit (annual)
- ₹101.4 Cr
- P/E (TTM)
- 18.2×Sector 57.8×
- Promoter holding
- 27.11%+0.00% QoQ
- FII holding
- 4.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krsnaa Diagnostics Ltd
All →Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics Ltd reported the successful passing of a special resolution via postal ballot approving the issuance of up to 16,21,000 convertible warrants to promoters.
Krsnaa Diagnostics Bags New Order from Department of Health & Family Welfare, Government of Punjab
Krsnaa Diagnostics executed a 15-year concession agreement with the Punjab Government to develop and operate PET-CT diagnostic facilities at four government hospitals.
- From
- Department of Health & Family Welfare, Government of Punjab
- Execution
- 15 years
- diagnostic facilities
- 4.0 hospitals
Krsnaa Diagnostics Legal & Regulatory
Krsnaa Diagnostics received tax appellate orders for AY 2017-24 with aggregate disputed demands of ₹62.69 Crore. The company plans to file further appeals.
- Value
- ₹62.69 Cr
Krsnaa Diagnostics Other Announcement
Krsnaa Diagnostics has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as required by regulatory listing obligations.
Krsnaa Diagnostics Annual General Meeting
Krsnaa Diagnostics Limited has submitted the notice of its 16th Annual General Meeting, scheduled for September 28, 2026, along with the Annual Report for 2025-26.
Krsnaa Diagnostics Earnings Call Transcript: Key Takeaways
Krsnaa reported 22% revenue growth but suffered margin compression due to heavy front-ended costs for the Rajasthan project. Management pivots to 'long-term value' to deflect from current EBITDA and PAT dips.
- Call
- Guides 100% growth